aluates Reports

$ 0.0

Automative

Global Peptide-based Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-30R5170

Global Peptide based Drug Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Peptide-based Drug Market Research Report 2025

Code: QYRE-Auto-30R5170

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

TEVA

Novo Nordisk

Takeda

Eli Lilly

Astrazeneca plc

Novartis

AbbVie

Ipsen S A

Ferring

Merck

The Medicines

J & J

Peptide-based Drug Market Size

The global market for Peptide-based Drug was valued at US$ 40090 million in the year 2024 and is projected to reach a revised size of US$ 72680 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Peptide-based Drug Market

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.

This report aims to provide a comprehensive presentation of the global market for Peptide-based Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-based Drug.

The Peptide-based Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide-based Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide-based Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide-based Drug Market Report

Report Metric	Details
Report Name	Peptide-based Drug Market
Accounted market size in year	US$ 40090 million
Forecasted market size in 2031	US$ 72680 million
CAGR	9.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Injection Oral Other
Segment by Application	Cancer Metabolic Disorders Central Nervous System Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, J & J
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide-based Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide-based Drug Market growing?

Ans: The Peptide-based Drug Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Peptide-based Drug Market size in 2031?

Ans: The Peptide-based Drug Market size in 2031 will be US$ 72680 million.

Who are the main players in the Peptide-based Drug Market report?

Ans: The main players in the Peptide-based Drug Market are Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, J & J

What are the Application segmentation covered in the Peptide-based Drug Market report?

Ans: The Applications covered in the Peptide-based Drug Market report are Cancer, Metabolic Disorders, Central Nervous System, Other

What are the Type segmentation covered in the Peptide-based Drug Market report?

Ans: The Types covered in the Peptide-based Drug Market report are Injection, Oral, Other

Recommended Reports

Peptide Therapeutics

Amino Acids & Synthesis

Related Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide-based Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Injection

1.2.3 Oral

1.2.4 Other

1.3 Market by Application

1.3.1 Global Peptide-based Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Metabolic Disorders

1.3.4 Central Nervous System

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide-based Drug Market Perspective (2020-2031)

2.2 Global Peptide-based Drug Growth Trends by Region

2.2.1 Global Peptide-based Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide-based Drug Historic Market Size by Region (2020-2025)

2.2.3 Peptide-based Drug Forecasted Market Size by Region (2026-2031)

2.3 Peptide-based Drug Market Dynamics

2.3.1 Peptide-based Drug Industry Trends

2.3.2 Peptide-based Drug Market Drivers

2.3.3 Peptide-based Drug Market Challenges

2.3.4 Peptide-based Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide-based Drug Players by Revenue

3.1.1 Global Top Peptide-based Drug Players by Revenue (2020-2025)

3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2020-2025)

3.2 Global Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide-based Drug Revenue

3.4 Global Peptide-based Drug Market Concentration Ratio

3.4.1 Global Peptide-based Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Drug Revenue in 2024

3.5 Global Key Players of Peptide-based Drug Head office and Area Served

3.6 Global Key Players of Peptide-based Drug, Product and Application

3.7 Global Key Players of Peptide-based Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide-based Drug Breakdown Data by Type

4.1 Global Peptide-based Drug Historic Market Size by Type (2020-2025)

4.2 Global Peptide-based Drug Forecasted Market Size by Type (2026-2031)

5 Peptide-based Drug Breakdown Data by Application

5.1 Global Peptide-based Drug Historic Market Size by Application (2020-2025)

5.2 Global Peptide-based Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide-based Drug Market Size (2020-2031)

6.2 North America Peptide-based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide-based Drug Market Size by Country (2020-2025)

6.4 North America Peptide-based Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide-based Drug Market Size (2020-2031)

7.2 Europe Peptide-based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide-based Drug Market Size by Country (2020-2025)

7.4 Europe Peptide-based Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide-based Drug Market Size (2020-2031)

8.2 Asia-Pacific Peptide-based Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide-based Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide-based Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide-based Drug Market Size (2020-2031)

9.2 Latin America Peptide-based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide-based Drug Market Size by Country (2020-2025)

9.4 Latin America Peptide-based Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide-based Drug Market Size (2020-2031)

10.2 Middle East & Africa Peptide-based Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide-based Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide-based Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Peptide-based Drug Introduction

11.1.4 Sanofi Revenue in Peptide-based Drug Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Peptide-based Drug Introduction

11.2.4 Teva Revenue in Peptide-based Drug Business (2020-2025)

11.2.5 Teva Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Peptide-based Drug Introduction

11.3.4 Novo Nordisk Revenue in Peptide-based Drug Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Peptide-based Drug Introduction

11.4.4 Takeda Revenue in Peptide-based Drug Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Peptide-based Drug Introduction

11.5.4 Eli Lilly Revenue in Peptide-based Drug Business (2020-2025)

11.5.5 Eli Lilly Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Peptide-based Drug Introduction

11.6.4 AstraZeneca Revenue in Peptide-based Drug Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Peptide-based Drug Introduction

11.7.4 Novartis Revenue in Peptide-based Drug Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Peptide-based Drug Introduction

11.8.4 AbbVie Revenue in Peptide-based Drug Business (2020-2025)

11.8.5 AbbVie Recent Development

11.9 Ipsen

11.9.1 Ipsen Company Details

11.9.2 Ipsen Business Overview

11.9.3 Ipsen Peptide-based Drug Introduction

11.9.4 Ipsen Revenue in Peptide-based Drug Business (2020-2025)

11.9.5 Ipsen Recent Development

11.10 Ferring

11.10.1 Ferring Company Details

11.10.2 Ferring Business Overview

11.10.3 Ferring Peptide-based Drug Introduction

11.10.4 Ferring Revenue in Peptide-based Drug Business (2020-2025)

11.10.5 Ferring Recent Development

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Peptide-based Drug Introduction

11.11.4 Merck Revenue in Peptide-based Drug Business (2020-2025)

11.11.5 Merck Recent Development

11.12 The Medicines

11.12.1 The Medicines Company Details

11.12.2 The Medicines Business Overview

11.12.3 The Medicines Peptide-based Drug Introduction

11.12.4 The Medicines Revenue in Peptide-based Drug Business (2020-2025)

11.12.5 The Medicines Recent Development

11.13 J & J

11.13.1 J & J Company Details

11.13.2 J & J Business Overview

11.13.3 J & J Peptide-based Drug Introduction

11.13.4 J & J Revenue in Peptide-based Drug Business (2020-2025)

11.13.5 J & J Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

TEVA

Novo Nordisk

Takeda

Eli Lilly

Astrazeneca plc

Novartis

AbbVie

Ipsen S A

Ferring

Merck

The Medicines

J & J

List of Tables

Table 1. Global Peptide-based Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Injection

Table 3. Key Players of Oral

Table 4. Key Players of Other

Table 5. Global Peptide-based Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peptide-based Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Peptide-based Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Peptide-based Drug Market Share by Region (2020-2025)

Table 9. Global Peptide-based Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Peptide-based Drug Market Share by Region (2026-2031)

Table 11. Peptide-based Drug Market Trends

Table 12. Peptide-based Drug Market Drivers

Table 13. Peptide-based Drug Market Challenges

Table 14. Peptide-based Drug Market Restraints

Table 15. Global Peptide-based Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Peptide-based Drug Market Share by Players (2020-2025)

Table 17. Global Top Peptide-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2024)

Table 18. Ranking of Global Top Peptide-based Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Peptide-based Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Peptide-based Drug, Headquarters and Area Served

Table 21. Global Key Players of Peptide-based Drug, Product and Application

Table 22. Global Key Players of Peptide-based Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Peptide-based Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Peptide-based Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Peptide-based Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Peptide-based Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Peptide-based Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Peptide-based Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Peptide-based Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Peptide-based Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Peptide-based Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Peptide-based Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Peptide-based Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Peptide-based Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Peptide-based Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Peptide-based Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Peptide-based Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Peptide-based Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Peptide-based Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Peptide-based Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Peptide-based Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Peptide-based Drug Product

Table 50. Sanofi Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 51. Sanofi Recent Development

Table 52. Teva Company Details

Table 53. Teva Business Overview

Table 54. Teva Peptide-based Drug Product

Table 55. Teva Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 56. Teva Recent Development

Table 57. Novo Nordisk Company Details

Table 58. Novo Nordisk Business Overview

Table 59. Novo Nordisk Peptide-based Drug Product

Table 60. Novo Nordisk Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 61. Novo Nordisk Recent Development

Table 62. Takeda Company Details

Table 63. Takeda Business Overview

Table 64. Takeda Peptide-based Drug Product

Table 65. Takeda Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 66. Takeda Recent Development

Table 67. Eli Lilly Company Details

Table 68. Eli Lilly Business Overview

Table 69. Eli Lilly Peptide-based Drug Product

Table 70. Eli Lilly Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 71. Eli Lilly Recent Development

Table 72. AstraZeneca Company Details

Table 73. AstraZeneca Business Overview

Table 74. AstraZeneca Peptide-based Drug Product

Table 75. AstraZeneca Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 76. AstraZeneca Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Peptide-based Drug Product

Table 80. Novartis Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 81. Novartis Recent Development

Table 82. AbbVie Company Details

Table 83. AbbVie Business Overview

Table 84. AbbVie Peptide-based Drug Product

Table 85. AbbVie Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 86. AbbVie Recent Development

Table 87. Ipsen Company Details

Table 88. Ipsen Business Overview

Table 89. Ipsen Peptide-based Drug Product

Table 90. Ipsen Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 91. Ipsen Recent Development

Table 92. Ferring Company Details

Table 93. Ferring Business Overview

Table 94. Ferring Peptide-based Drug Product

Table 95. Ferring Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 96. Ferring Recent Development

Table 97. Merck Company Details

Table 98. Merck Business Overview

Table 99. Merck Peptide-based Drug Product

Table 100. Merck Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 101. Merck Recent Development

Table 102. The Medicines Company Details

Table 103. The Medicines Business Overview

Table 104. The Medicines Peptide-based Drug Product

Table 105. The Medicines Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 106. The Medicines Recent Development

Table 107. J & J Company Details

Table 108. J & J Business Overview

Table 109. J & J Peptide-based Drug Product

Table 110. J & J Revenue in Peptide-based Drug Business (2020-2025) & (US$ Million)

Table 111. J & J Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Peptide-based Drug Picture

Figure 2. Global Peptide-based Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide-based Drug Market Share by Type: 2024 VS 2031

Figure 4. Injection Features

Figure 5. Oral Features

Figure 6. Other Features

Figure 7. Global Peptide-based Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Peptide-based Drug Market Share by Application: 2024 VS 2031

Figure 9. Cancer Case Studies

Figure 10. Metabolic Disorders Case Studies

Figure 11. Central Nervous System Case Studies

Figure 12. Other Case Studies

Figure 13. Peptide-based Drug Report Years Considered

Figure 14. Global Peptide-based Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Peptide-based Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Peptide-based Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Peptide-based Drug Market Share by Players in 2024

Figure 18. Global Top Peptide-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Peptide-based Drug Revenue in 2024

Figure 20. North America Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Peptide-based Drug Market Share by Country (2020-2031)

Figure 22. United States Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Peptide-based Drug Market Share by Country (2020-2031)

Figure 26. Germany Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Peptide-based Drug Market Share by Region (2020-2031)

Figure 34. China Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Peptide-based Drug Market Share by Country (2020-2031)

Figure 42. Mexico Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Peptide-based Drug Market Share by Country (2020-2031)

Figure 46. Turkey Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Peptide-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Sanofi Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 50. Teva Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 51. Novo Nordisk Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 52. Takeda Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 56. AbbVie Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 57. Ipsen Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 58. Ferring Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 59. Merck Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 60. The Medicines Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 61. J & J Revenue Growth Rate in Peptide-based Drug Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injection Peptide Drug Market Research Report 2025

Global Peptide Building Block Market Insights Forecast to 2030

Peptide based Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Peptide Drugs Market Research Report 2024

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Global Peptide based Generics Market Research Report 2024

Global Clinical Peptide Market Research Report 2024

Proteins Amino Acids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Antibiotics Sterile Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CMO Peptide Market Research Report 2025

Global Peptide Synthesis Market Insights Forecast to 2030

Global Oral Proteins and Peptides Market Research Report 2025

Global Chemical Synthesis Peptide Drugs Market Research Report 2024

Global Pharmaceutical Amino Acids Market Research Report 2025

Global Peptide Synthesis Service Market Insights Forecast to 2030

Global Bio active Peptides Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions